CT
CDNA icon

Colonial Trust’s CareDx CDNA Stock Holding History

Colonial Trust’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-79
Closed -$902 – 905
2022
Q4 		$902 Buy
+79
New +$1.17K ﹤0.01% 882

Other funds holding CDNA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Colonial Trust's CDNA Position: Q1 2023 in Review

Colonial Trust sold out of CareDx (CDNA) in Q1 2023, closing a stake of 79 shares — an estimated $902 sold.

Colonial Trust first reported a position in CDNA in Q4 2022 and held it in 1 quarter. The position peaked at $902 in Q4 2022. 156 funds tracked by Wall St. Rank hold CDNA as of Q1 2023.

  • Colonial Trust reported no remaining CareDx position as of Q1 2023 after selling out during the quarter.
  • Colonial Trust sold 79 CareDx shares in Q1 2023, an estimated $902.
  • Colonial Trust first reported a position in CareDx in Q4 2022 and held it in 1 quarter.
  • Colonial Trust's CareDx position peaked at $902 in Q4 2022.
  • 156 funds tracked by Wall St. Rank held CareDx as of Q1 2023.

Based on Colonial Trust's 13F filing for Q1 2023, filed 11 May 2023.